Meningococcal Vaccines: Challenges and Prospects

Affiliations

¹ Center for Drug Delivery Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
² Fraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711, USA.
³ College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.

Editorial

Priyal Bagwe et al. Vaccines (Basel). 2020.

. 2020 Dec 4;8(4):738.

doi: 10.3390/vaccines8040738.

¹ Center for Drug Delivery Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
² Fraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711, USA.
³ College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.

Abstract

Neisseria meningitidis is a gram-negative bacterium that causes a severe acute infection, called the meningococcal disease [...].

The authors declare no conflict of interest.

1. World Health Organization (WHO) Meningococcal Meninigitis: Emergency Preparedness and Response. [(accessed on 13 September 2020)]; Available online: http://www.who.int/csr/disease/meningococcal/en/
1. Center for Disease Control and Prevention (CDC), The Pink Book Immunology and Vaccines—Preventable Diseases—Meningococcal Disease. [(accessed on 20 September 2020)]; Available online: https://www.cdc.gov/vaccines/pubs/pinkbook/index.html.
1. Borrow R., Alarcón P., Carlos J. The Global Meningococcal Initiative: Global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Rev. Vaccines. 2017;16:313–328. doi: 10.1080/14760584.2017.1258308. - DOI - PubMed
1. Feavers I.M., Maiden M.C.J. Recent progress in the prevention of serogroup B meningococcal disease. Clin. Vaccine Immunol. 2017;24:e00566-16. doi: 10.1128/CVI.00566-16. - DOI - PMC - PubMed
1. Donald R.G.K., Hawkins J.C., Hao L., Liberator P., Jones T.R., Harris S.L., Perez J.L., Eiden J.J., Jansen K.U., Anderson A.S. Meningococcal serogroup B vaccines: Estimating breadth of coverage. Hum. Vaccines Immunother. 2017;13:255–265. doi: 10.1080/21645515.2017.1264750. - DOI - PMC - PubMed